- Company Overview for SCARLET THERAPEUTICS LIMITED (13536278)
- Filing history for SCARLET THERAPEUTICS LIMITED (13536278)
- People for SCARLET THERAPEUTICS LIMITED (13536278)
- More for SCARLET THERAPEUTICS LIMITED (13536278)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
22 Aug 2022 | MA | Memorandum and Articles of Association | |
17 Aug 2022 | AP01 | Appointment of Dr Harry Stephen Destecroix as a director on 12 August 2022 | |
17 Aug 2022 | SH01 |
Statement of capital following an allotment of shares on 12 August 2022
|
|
02 Aug 2022 | CS01 | Confirmation statement made on 27 July 2022 with updates | |
01 Aug 2022 | PSC04 | Change of details for Professor Ashley Mark Toye as a person with significant control on 15 July 2022 | |
20 Jul 2022 | RESOLUTIONS |
Resolutions
|
|
20 Jul 2022 | SH02 | Sub-division of shares on 15 July 2022 | |
15 Jul 2022 | SH01 |
Statement of capital following an allotment of shares on 15 July 2022
|
|
14 Jul 2022 | AD01 | Registered office address changed from 1 Cathedral Square Bristol BS1 5DD England to C/O Veale Wasbrough Vizards Llp Narrow Quay House Narrow Quay Bristol BS1 4QA on 14 July 2022 | |
28 Jul 2021 | NEWINC |
Incorporation
Statement of capital on 2021-07-28
|